Background illustration for clinical trials search

Paid Clinical Trials Kansas

Discover 803 paid clinical trials in Kansas. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease

for
Graves' Disease, Graves Disease
Location: New York NY, Fort Lauderdale FL, Kissimmee FL,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT07570316

Phase3, Recruiting
Active & Responsive

Safety of MOON101 for the Treatment of Peanut Allergy

for
Peanut Allergy
Location: Chapel Hill NC, Atlanta GA, Ann Arbor MI,
Sponsor: Moonlight Therapeutics, Inc.

Sex: All

Age: 4 - 55

Code: NCT07580898

Phase1, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

for
Pulmonary Arterial Hypertension
Location: Philadelphia PA, Rochester NY, Anderson SC,
Sponsor: Insmed Incorporated

Sex: All

Age: 18 - 70+

Code: NCT07481981

Phase3, Recruiting
Active & Responsive

A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer

for
Castration Resistant Metastatic Prostate Cancer,
Location: Boston MA, Miami FL, Grand Rapids MI, Kansas City KS,
Sponsor: Aktis Oncology, Inc.

Sex: Male

Age: 18+

Code: NCT07581184

Phase1, Recruiting
Active & Responsive

Phase 2 Study to Assess the Safety and Efficacy of ANG003

for
Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Location: Boston MA, New Brunswick NJ, Hershey PA, Akron OH,
Sponsor: Anagram Therapeutics, Inc.

Sex: All

Age: 12+

Code: NCT07450547

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

for
Macular Degeneration, Age-Related Macular Degeneration,
Location: Portland ME, Waterford CT, Manchester CT,
Sponsor: EyeBiotech Ltd.

Sex: All

Age: 50+

Code: NCT07496567

Phase2, Phase3, Recruiting
Active & Responsive

Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

for
Type II Diabetes Mellitus
Location: Hialeah Gardens FL, Miami FL, Orlando FL, Lakeland FL,
Sponsor: Sun Pharmaceutical Industries Limited

Sex: All

Age: 18+

Code: NCT07282743

Phase2, Recruiting
Active & Responsive

NEPTUNE Match Study

for
Nephrotic Syndrome in Children,
Location: New Hyde Park NY, New York NY, Philadelphia PA,
Sponsor: University of Michigan

Sex: All

Age: 1 - 70+

Code: NCT04571658

Recruiting
Active & Responsive

Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)

for
Muscular Dystrophy, Facioscapulohumeral
Location: Rochester NY, Durham NC, Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 5 - 17

Code: NCT06847282

Recruiting
Active & Responsive

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

for
Pulmonary Hypertension, Interstitial Lung Disease (ILD),
Location: Boston MA, Providence RI, Charleston SC, Greensboro NC,
Sponsor: Pulmovant, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07333183

Phase2, Recruiting
Active & Responsive

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

for
AML With Gene Mutations
Location: New York NY, College Park MD, Chapel Hill NC,
Sponsor: Lomond Therapeutics Holdings, Inc.

Sex: All

Age: 18+

Code: NCT06366789

Phase1, Recruiting
Active & Responsive

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.

for
Spasticity
Location: Elkins Park PA, Overland Park KS, Dallas TX, Downey CA
Sponsor: Ipsen

Sex: All

Age: 18 - 70

Code: NCT04752774

Phase1, Phase2, Recruiting
Active & Responsive

Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)

for
Cystic Fibrosis
Location: Boston MA, Wilmington DE, Baltimore MD, Orlando FL,
Sponsor: Boston Children's Hospital

Sex: All

Age: 6+

Code: NCT06683092

Recruiting
Active & Responsive

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Stony Brook NY, Wilmington DE, Chadds Ford PA,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07441681

Phase3, Recruiting
Active & Responsive

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

for
Extensive Stage Lung Small Cell Carcinoma,
Location: North Haven CT, New Haven CT, Trumbull CT, New York NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06287775

Phase1, Phase2, Recruiting
Active & Responsive

A Phase 1 Randomized, Observer-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health

for
Marburg Virus Disease
Location: Washington D.C. DC, Lenexa KS
Sponsor: International AIDS Vaccine Initiative

Sex: All

Age: 18 - 50

Code: NCT07425821

Phase1, Recruiting
Active & Responsive

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

for
Parkinson Disease
Location: Boston MA, New York NY, Durham NC, Boca Raton FL,
Sponsor: Appello Pharmaceuticals, Inc.

Sex: All

Age: 30 - 70+

Code: NCT07432958

Phase2, Recruiting
Active & Responsive

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

for
Lung Cancer Diagnosis
Location: Hyannis MA, Stamford CT, Mullica Hill NJ,
Sponsor: Freenome Holdings Inc.

Sex: All

Age: 50+

Code: NCT06122077

Recruiting
Active & Responsive

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: Boston MA, New Haven CT, New York NY, New Brunswick NJ,
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT05303519

Phase3, Recruiting
Active & Responsive

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06982521

Phase3, Recruiting

Popular cities in Kansas

With a well-established healthcare network and renowned medical research institutions, Kansas has emerged as a significant hub for a wide range of clinical trials. Leading institutions such as The University of Kansas Medical Center, Wesley Medical Center, and Children's Mercy Kansas City are at the forefront of groundbreaking studies.

These centers are recognized for their contributions to innovative medical research, helping to advance treatments in fields such as oncology, cardiology, and pediatrics.

Why choose Kansas for clinical trials?

Kansas offers unique advantages for those participating in clinical trials. The state’s central location, combined with a mix of urban and rural populations, provides a diverse range of participants, making research findings more comprehensive and applicable to various communities. Kansas is also known for its collaborative research environment, where major institutions work closely with local healthcare providers to drive medical advancements.

By participating in a clinical trial in Kansas, volunteers contribute to critical research efforts while benefiting from a supportive, patient-focused clinical research system that emphasizes innovation and community engagement.

Common conditions studied in Kansas

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Kansas